Alisa Lask is VP and GM, U.S. aesthetic business unit of Galderma, Nestlé Skin Health.
Neera Chaudhary is global president of healthcare of Golin.
Wendy Blackburn is EVP, marketing and communications of Intouch Solutions.
Wendy Lund is CEO of GCI Health.
Vanessa Thirion-Cullity is executive director, U.S. NET of Novartis Oncology.
MM&M is honoring 20 Women to Watch, aspiring healthcare commercial and marketing execs changing the face of the industry.
MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.
Califf spoke about the importance of more data to faster and cheaper drug development at the NewYorkBIO conference.
Whether jurors will award a pharma Grand Prix, and whether US pharma will show up, are two open questions in the run-up to Lions Health.
Here's a recap of the Novartis-Michael Cohen crisis, which unfolded this week, including how the drugmaker has responded to scrutiny over its $1.2 million contract with Cohen's firm.
At the Asembia Specialty Pharma summit, speakers described a healthcare ecosystem in which specialty products will represent nearly half of all drug spending.
Paul LeVine, VP, Analytic Services for TrialCard, describes proven strategies that prevent patient adherence fall off, driven by evidenced-based design and patient engagement programs.
Pharma giant GlaxoSmithKline has reportedly launched a review of its $1.76 billion global media agency arrangements, putting MediaCom and PHD on alert.
The healthcare sector has suffered a dip in public trust in major markets including France, India and the US, but Britons remain among the more trusting globally, according to the Edelman Health Trust Barometer.
Gary Scheiner, EVP and chief creative officer at GHG, discusses the inherent tension in day-to-day marketing for healthcare brands.
Both leaders were honored at Healthcare Businesswomen's Association 2018 Woman of the Year event in New York.
Remedy Health Media's Mike Collins discusses ways pharma and healthcare companies have shifted their strategies in the years after the success of blockbuster drugs.
Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised for their value.
Anatomy of Agency Culture is a supplement designed not only to showcase internal programs, but to examine them with an eye on how they impact company culture.
Four agencies are making a difference by supporting nonprofits, educating and empowering youth, and promoting wellness and sustainability in communities around the world
Croom Lawrence and Kent Groves of Merkle Health explain being human.
Rbb Communications' EVP of global and emerging markets, healthcare Srikant Ramaswami discusses how he keeps sane with his busy schedule and what inspires him.
Those on the vanguard of transformation include a number of upstarts and veteran gurus taking on historic challenges plaguing health data.
Here are the 40 upstarts and veterans who are transforming the healthcare industry.
Heather Bell is SVP, global head of digital and analytics of Sanofi.
Ozgun Demir is the director, digital strategy at Novartis.
Nick Desai is cofounder and CEO of Heal.
David Ebersman is cofounder and CEO of Lyra Health.
Jamey Edwards is CEO of Cloudbreak Health.
Amy Foley is VP, product innovation and delivery at Johnson & Johnson.